Bellevue Healthcare Strategy I

Reference Data

ISIN LU1477742818
Valor Number
Bloomberg Global ID
Fund Name Bellevue Healthcare Strategy I
Fund Provider Bellevue Asset Management AG Zürich, Switzerland
Phone: +41 44 267 67 00
E-Mail: info@bellevue.ch
Web: www.bellevue.ch
Fund Provider Bellevue Asset Management AG
Representative in Switzerland Waystone Fund Services (Switzerland) SA
Lausanne
Phone: 0041213111781
Distributor(s) Bank am Bellevue AG
Küsnacht
Phone: +41 44 267 67 67
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition Combination of issuing commission charged by the fund management company and transaction fee charged by the fund
Redemption Condition Combination of redemption commission charged by the fund management company and transaction fee charged by the fund
Investment Strategy *** The Sub-fund is an actively managed equity fund. It is based on the Bellevue Healthcare Strategy that has been in existence since 2007. The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two-thirds of the net assets of Bellevue Healthcare Strategy in a portfolio of carefully chosen shares and other equity securities of companies in the healthcare industry, or companies whose main activity consists of holding shares in such companies or financing such companies and who have their registered office or carry out the majority of their economic activity in recognised countries.
Peculiarities

Fund Prices

Current Price * 248.85 USD 07.11.2024
Previous Price * 246.59 USD 06.11.2024
52 Week High * 262.61 USD 30.08.2024
52 Week Low * 220.56 USD 10.11.2023
NAV * 248.85 USD 07.11.2024
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 416,623,604
Unit/Share Assets ***
Trading Information SIX

Performance

YTD Performance +6.15% 29.12.2023
07.11.2024
YTD Performance (in CHF) +10.05% 29.12.2023
07.11.2024
1 month -0.98% 07.10.2024
07.11.2024
3 months +2.06% 07.08.2024
07.11.2024
6 months +3.80% 07.05.2024
07.11.2024
1 year +11.95% 07.11.2023
07.11.2024
2 years +10.26% 07.11.2022
07.11.2024
3 years -8.66% 08.11.2021
07.11.2024
5 years -11.55% 15.06.2021
07.11.2024

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Eli Lilly and Co 3.41%
Regeneron Pharmaceuticals Inc 3.39%
HCA Healthcare Inc 3.33%
Vertex Pharmaceuticals Inc 3.22%
Boston Scientific Corp 3.07%
Insulet Corp 3.06%
UCB SA 3.03%
UnitedHealth Group Inc 3.00%
Stryker Corp 2.84%
IQVIA Holdings Inc 2.83%
Last data update 31.08.2024

Cost / Risk

TER 1.54%
TER date 29.01.2021
Performance Fee *** 0.00%
PTR
Max. Management Fee *** 0.90%
Ongoing Charges *** 1.50%
SRRI ***
SRRI date *** 31.10.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)